( NASDAQ-NMS:JAZZ )

News from jazz pharmaceuticals plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 09, 2016, 16:05 ET Jazz Pharmaceuticals Announces Second Quarter 2016 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2016 and updated financial guidance for...


Aug 02, 2016, 19:15 ET CMS Grants New Technology Add-On Payment to Defitelio for the Treatment of Hepatic Veno-Occlusive Disease with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the United States (U.S.) Centers for Medicare and Medicaid Services (CMS)...


Jul 28, 2016, 16:05 ET Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to Product Candidates in Early Development for Hematological Malignancies

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Pfenex Inc. (NYSE MKT: PFNX) today announced an agreement under which Pfenex granted Jazz...


Jul 25, 2016, 16:05 ET Jazz Pharmaceuticals to Report 2016 Second Quarter Financial Results on August 9, 2016

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 second quarter financial results on Tuesday, August 9, 2016,...


Jul 12, 2016, 01:50 ET Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common Stock of Celator Pharmaceuticals, Inc.

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the results of its tender offer to purchase all of the outstanding shares of common...


Jun 27, 2016, 00:09 ET Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as...


Jun 14, 2016, 16:05 ET Jazz Pharmaceuticals Announces Conference Call and Webcast for JZP-110 Investor Update

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it is hosting an investor conference call and audio webcast on Monday, June 20, 2016...


Jun 03, 2016, 18:21 ET Celator Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of CPXX Shareholders

 WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Celator...


May 31, 2016, 03:30 ET Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today announced that they have entered into a definitive...


May 27, 2016, 11:41 ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jazz Pharmaceuticals plc - JAZZ

 Pomerantz LLP is investigating claims on behalf of investors of Jazz Pharmaceuticals plc ("Jazz" or the Company) (NASDAQ: JAZZ).  Such...


May 18, 2016, 16:05 ET Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...


May 10, 2016, 16:05 ET Jazz Pharmaceuticals Announces First Quarter 2016 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2016 and updated financial guidance for...


Apr 26, 2016, 16:05 ET Jazz Pharmaceuticals to Report 2016 First Quarter Financial Results on May 10, 2016

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 first quarter financial results on Tuesday, May 10, 2016,...


Mar 30, 2016, 14:41 ET Jazz Pharmaceuticals Announces Webcast for Defitelio® (defibrotide sodium) Investor Update

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Thursday, March 31, 2016 at 4:30 p.m. EDT/9:30 p.m....


Mar 30, 2016, 14:32 ET Jazz Pharmaceuticals Announces FDA Approval of Defitelio® (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease (VOD) with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (HSCT)

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the United States (U.S.) Food and Drug Administration (FDA) granted...


Mar 02, 2016, 16:05 ET Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...


Feb 23, 2016, 16:05 ET Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2015 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter of 2015 and provided...


Feb 18, 2016, 09:05 ET Jazz Pharmaceuticals To Present Data From Ongoing Evaluations Of Defibrotide At The 2016 BMT Tandem Meeting

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that researchers will present three Jazz-sponsored oral abstracts related to the...


Feb 09, 2016, 16:05 ET Jazz Pharmaceuticals to Report 2015 Fourth Quarter and Full Year Financial Results on February 23, 2016

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2015 fourth quarter and full year financial results on...


Feb 01, 2016, 09:05 ET Results from Phase 3 Trial of Defibrotide for the Treatment of Severe Veno-Occlusive Disease and Multi-Organ Failure Published Online in BLOOD

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that data from the phase 3 pivotal study of defibrotide were published online in...


Jan 04, 2016, 16:05 ET Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 11

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 34th Annual J.P....


Nov 04, 2015, 16:05 ET Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at three upcoming investor...


Sep 30, 2015, 08:30 ET Jazz Pharmaceuticals Announces U.S. FDA Acceptance for Filing with Priority Review of NDA for Defibrotide for Hepatic Veno-Occlusive Disease

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted for...


Aug 05, 2015, 16:05 ET Jazz Pharmaceuticals Announces Second Quarter 2015 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2015 and reaffirmed financial guidance for...


Jun 08, 2015, 09:05 ET Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Clinical Development Program Evaluating JZP-110 as a Potential Treatment of Excessive Daytime Sleepiness (EDS) Associated with Narcolepsy or with Obstructive Sleep Apnea (OSA)

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the first patients have been enrolled in a Phase 3 clinical development...